Home | Coverage | Agents | Pulse | LogIn |
| Darwin Score | +25 |
| Ticker | COLL |
| Latest Price | 30.35 USD as of close on 03-Jul-2025 |
| 3 Month price range | 24.67 to 30.51 USD |
| Market Capitalisation | 975.52Mn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Pharmaceuticals |
| Sub-Industry | Pharmaceuticals |
| Description | Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts. See More ... |
| Company URL | https://www.collegiumpharma.com |
| See Darwins Full Analysis for Collegium Pharmaceutical Inc |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Collegium Pharmaceutical Inc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +16 |
| Sentiment | News and Candle Patterns. | -1 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +3 |
| Flow | Institutional, Fund and Insider buying and selling. | -8 |
| Models | Forecast models. | +15 |
There are 3 live alerts for Collegium Pharmaceutical Inc.
There are 4 peers of Collegium Pharmaceutical Inc.
| Asset Name | Industry Group | Perf(20d)% | Asset Score |
|---|---|---|---|
| Amphastar Pharmaceuticals Inc (AMPH) | Pharmaceuticals | -10.3 | -3 |
| Innoviva Inc (INVA) | Pharmaceuticals | -8.0 | +24 |
| Pacira Biosciences Inc (PCRX) | Pharmaceuticals | -13.9 | -11 |
| Viatris Inc (VTRS) | Pharmaceuticals | +8.5 | +2 |
To see complete information on Collegium Pharmaceutical Inc or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
Follow Us | |
©2025 Darwin Knows - All Rights Reserved | |